Technology ID
TAB-4661

Novel Reassortant Mammalian Orthoreovirus Isolate for the Development of Vaccines and Diagnostic Tools

E-Numbers
E-130-2019-0
Lead Inventor
Wang, Liping
Lead IC
CDC
Co-Inventors
Ma, Wenjun
Tong, Suxiang (Sue)
ICs
CDC
Applications
Vaccines­­­
Therapeutics
Research Materials
Diagnostics
Development Stages
Pre-clinical (in vivo)

This technology includes a novel, isolated reassortant mammalian Orthoreovirus (MRV) isolated from pigs with neurological symptoms, for use in the development of vaccines and diagnostic tests. This isolate has S1 gene from MRV1 closed to bovine isolated, M2 gene from MRV2 and other 8 genes from MRV3 based on full-genome sequence analysis. MRV3 has been reported and isolated from the US pigs with diarrhea symptom. Compared to the reported swine MRV3 isolates that cause diarrhea in pigs, the novel reassortant MRV causes neurological disease in pigs.

Commercial Applications
Development of vaccines and diagnostic tools.

Competitive Advantages
This is the first time to report that the novel reassortant MRV causes neurological disease in pigs.
Licensing Contact:
Motley, Jonathan
jonathan.motley@nih.gov